NCT05244720View on ClinicalTrials.gov

Evaluation of Liver Disease in Individuals Attending Alcohol Abuse Treatment - a Randomized Controlled Pilot Trial

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2022

Conditions

Liver Diseases

Interventions

DIAGNOSTIC_TEST

Fibroscan

A percutaneous scan, that measures shear wave velocity. It estimates liver stiffness.

DIAGNOSTIC_TEST

Blood samples

Blood samples to asses the function of liver, kidney and bone marrow, as well as nutrition/vitamin status.

Trial Locations (1)

4600

Department of Medicine, Zealand University Hospital, Køge

All Listed Sponsors

lead

Zealand University Hospital

OTHER

NCT05244720 - Evaluation of Liver Disease in Individuals Attending Alcohol Abuse Treatment - a Randomized Controlled Pilot Trial | Biotech Hunter | Biotech Hunter